%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2020-10-12T11:11:56-04:00
2020-10-12T11:12:05-04:00
2020-10-12T11:12:05-04:00
Adobe InDesign CC 13.1 (Windows)
uuid:c01678c1-1965-46ac-a4c7-231064055263
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
xmp.id:c275650c-38e5-7041-8a1a-3773f85c2c2b
proof:pdf
xmp.iid:b59b29fc-42ee-8e4d-a724-fc896000a574
xmp.did:bc3b9ae4-23f7-e74b-ace0-fc6f89ea878e
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 13.1 (Windows)
/
2020-10-12T11:11:56-04:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
12 0 obj
<>
endobj
3 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
6 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/Properties<>/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
14 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
68 0 obj
<>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc 8.5 0 0 8.5 171.2281 529.398 Tm
(1.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Regarding the study looking at nut)-10 ( )]TJ
0 -1.2 Td
[(consumption and cardiovascular disease)-10 ( )]TJ
0.01 Tw 0 -1.2 Td
(\(CVD\):)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tw 0 -1.2 Td
[(a. This randomized, controlled trial showed)-10 ( )]TJ
0 -1.2 Td
[(solid evidence of health bene\037ts of > 0.5)-10 ( )]TJ
0 -1.2 Td
[(daily servings \(or 0.5 ounces\) of nuts, except)-10 ( )]TJ
0 -1.2 Td
[(for peanuts \227 these did not appear to be)-10 ( )]TJ
0 -1.2 Td
(associated with any health bene\037ts.)Tj
0 -1.2 Td
[(b. This randomized, controlled trial showed)-10 ( )]TJ
0 -1.2 Td
[(that > 0.5 daily servings \(or 0.5 ounces\) of)-10 ( )]TJ
0 -1.2 Td
[(tree nuts, peanuts, and walnuts all were)-10 ( )]TJ
0 -1.2 Td
[(signi\037cantly associated with a decreased risk)-10 ( )]TJ
0 -1.2 Td
[(of CVD in women; results were less conclusive)-10 ( )]TJ
0 -1.2 Td
(in men.)Tj
0 -1.2 Td
[(c. This prospective study showed, when)-10 ( )]TJ
0 -1.2 Td
[(compared to individuals who did not change)-9.9 ( )]TJ
0 -1.2 Td
[(nut consumption, that an increase of > 0.5)-10 ( )]TJ
0 -1.2 Td
[(servings \(or 0.5 ounces\) of tree nuts, walnuts,)-10 ( )]TJ
0 -1.2 Td
[(or peanuts was signi\037cantly associated with)-10 ( )]TJ
0 -1.2 Td
[(a decreased risk of CVD, whereas a decrease)-10 ( )]TJ
0 -1.2 Td
[(of > 0.5 daily servings of tree nuts, walnuts,)-10 ( )]TJ
0 -1.2 Td
[(or peanuts was associated with a signi\037cant)-10 ( )]TJ
0 -1.2 Td
(increased risk of CVD.)Tj
0 -1.2 Td
[(d. This prospective study showed that > 0.5)-10 ( )]TJ
0 -1.2 Td
[(daily servings \(or 0.5 ounces\) of tree nuts,)-10 ( )]TJ
0 -1.2 Td
[(peanuts, and walnuts all were signi\037cantly)-10 ( )]TJ
0 -1.2 Td
[(associated with a decreased risk of CVD in)-9.9 ( )]TJ
0 -1.2 Td
(men; results were less conclusive in women.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
21.308 32.4 Td
(2.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Based on the results of the study by Meltzer et)-10 ( )]TJ
0 -1.2 Td
[(al, which is true for patients who are vitamin)-10 ( )]TJ
0 -1.2 Td
(D de\037cient and were untreated?)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 -1.2 Td
[(a. They were almost twice as likely to test)-10 ( )]TJ
0 -1.2 Td
(positive for COVID-19.)Tj
0 -1.2 Td
[(b. All races were affected equally)92 (.)]TJ
0 -1.2 Td
[(c. The severity risk tended to decrease with)-10 ( )]TJ
0.01 Tw 0 -1.2 Td
(age.)Tj
0 Tw 0 -1.2 Td
[(d. They were almost twice as likely to test)-10 ( )]TJ
0 -1.2 Td
(positive for seasonal in\036uenza.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-1.588 -2.894 Td
(3.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Which COVID-19 patients did not bene\037t)-10 ( )]TJ
0 -1.2 Td
(from dexamethasone?)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 -1.2 Td
(a. Patients requiring mechanical ventilation)Tj
0 -1.2 Td
[(b. Patients requiring ventilatory support and)-10 ( )]TJ
0 -1.2 Td
(supplemental oxygen)Tj
0 -1.2 Td
[(c. Patients requiring supplemental oxygen but)-10 ( )]TJ
0 -1.2 Td
(not invasive ventilatory support)Tj
0 -1.2 Td
(d. Patients not requiring supplemental oxygen)Tj
ET
endstream
endobj
69 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
/CS0 cs 0.07 scn
/GS0 gs
18 111.6 120.33 644.4 re
f
18 36 539.325 53.473 re
f
BT
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 7 0 0 7 27.8983 78.3659 Tm
(Interested in reprints or posting an article to your )Tj
0 -1.143 Td
[(company)-55.8 (\222s site? There are numerous opportunities for )]TJ
0 -1.143 Td
(you to leverage editorial recognition for the benefit of )Tj
0 -1.143 Td
(your brand. Call us at \(800\) 688-2421 or email us at )Tj
0 -1.143 Td
(reliasmedia)Tj
/C2_0 1 Tf
<0014>Tj
/TT0 1 Tf
(@gmail.com.)Tj
25.217 4.571 Td
(Discounts are available for group subscriptions, multiple )Tj
0 -1.143 Td
(copies, site licenses, or electronic distribution. For pricing )Tj
0 -1.143 Td
(information, please contact our Group Account Managers )Tj
0 -1.143 Td
(at groups@reliasmedia.com or \(866\) 213-0844.)Tj
19.248 0 Td
( )Tj
5.969 3.429 Td
[(T)175 (o reproduce any part of R)17.6 (elias Media newsletters for )]TJ
0 -1.143 Td
(educational purposes, please contact The Copyright )Tj
0 -1.143 Td
(Clearance Center for permission at info@copyright.com )Tj
0 -1.143 Td
(or \(978\) 750-8400.)Tj
ET
/CS0 CS 1 SCN
3 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 138.6633 754.5 cm
0 0 m
437.337 0 l
S
Q
/CS0 cs 1 scn
164.425 182.08 391.566 17.367 re
f
BT
0 scn
0.041 Tc -0.016 Tw 10 0 0 10 319.8918 187.3945 Tm
[(CM)1 (E)16 ( O)4.1 (B)11.9 (J)2.4 (E)24.3 (C)-1.4 (T)14.1 (I)0.5 (VE)9.9 (S)]TJ
ET
1 scn
163.328 543.513 392.414 18.174 re
f
0.25 w
163.391 241.045 392.225 302.343 re
S
BT
0 scn
0.037 Tc -0.012 Tw 10 0 0 10 318.7734 549.7422 Tm
[(C)-3.7 (M)-3 (E)12 ( Q)1.9 (U)-3.3 (E)5.9 (S)4.8 (T)10.1 (ION)-11.3 (S)]TJ
ET
0.07 scn
163.266 608.293 390.303 117.38 re
f
BT
0 0 0 1 k
/GS1 gs
/TT1 1 Tf
-0.02 Tc 0 Tw 9 0 0 9 171.0561 710.2389 Tm
[(T)174.8 (o earn credit for this activity)87 (, please follow these instructions:)]TJ
0 Tc 22.102 0 Td
( )Tj
-0.02 Tc -22.102 -1.222 Td
[(1. R)17.5 (ead and study the activity)87 (, using the provided references for further research.)]TJ
0 Tc 29.127 0 Td
( )Tj
-0.02 Tc -29.127 -1.222 Td
[(2. L)17.4 (og on to )]TJ
/TT0 1 Tf
0.02 Tw [(R)17.6 (eliasMedia.com)]TJ
/TT1 1 Tf
0 Tw [( and click on My Account. F)35.9 (irst-time users must register on the site. T)174.8 (ests are taken)-19.9 ( )]TJ
0 -1.222 Td
(after each issue.)Tj
0 Tc 5.741 0 Td
( )Tj
-0.02 Tc -5.741 -1.222 Td
[(3. P)54.7 (ass the online test with a score of 100%; you will be allowed to answer \
the questions as many times as needed)-20.3 ( )]TJ
0 -1.222 Td
[(to achieve a score of 100%.)-20 ( )]TJ
0 Tc 10.468 0 Td
( )Tj
-0.02 Tc -10.468 -1.222 Td
[(4. After successfully completing the test, your browser will be automati\
cally directed to the activity evaluation form,)-19.9 ( )]TJ
0 -1.222 Td
(which you will submit online.)Tj
0 -1.222 Td
(5. Once the completed evaluation is received, a credit letter will be em\
ailed to you.)Tj
ET
/CS0 cs 1 scn
/GS0 gs
161.24 725.673 392.33 17.367 re
f
BT
0 scn
/TT0 1 Tf
0.037 Tc -0.012 Tw 10 0 0 10 308.2834 731.2885 Tm
[(C)-3.7 (M)-3 (E)12 ( I)-1.3 (N)-11.4 (S)4.8 (T)7.7 (R)6.1 (U)2.7 (C)-5.3 (T)10.1 (ION)-11.3 (S)]TJ
1 scn
0.01 Tc 0 Tw 9 0 0 9 164.4585 168.2417 Tm
[(Upon completion of this educational activity)87.1 (, participants should be able to:)]TJ
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
0 Tc 7 0 0 7 25.2 743.396 Tm
(PHYSICIAN EDITOR)Tj
/TT0 1 Tf
0 -1.107 Td
(Stephen A. Brunton, MD)Tj
/TT1 1 Tf
-0.025 Tc 0 -1.107 Td
[(Adjunct P)35.6 (rofessor of Pharmacy P)35.7 (ractice)]TJ
0 -1.107 Td
(College of Pharmacy)Tj
0 Tc 7.469 0 Td
( )Tj
-0.025 Tc -7.469 -1.107 Td
[(R)17.5 (oseman University of Health Sciences)]TJ
0 Tc 13.998 0 Td
( )Tj
-0.025 Tc -13.998 -1.107 Td
[(Salt L)17.4 (ake City)]TJ
/T1_0 1 Tf
0 Tc 0 -2.5 Td
(PEER REVIEWER)Tj
/TT0 1 Tf
0 -1.107 Td
[(Gerald R)17.7 (oberts, MD)]TJ
/TT1 1 Tf
0 -1.107 Td
(Senior Attending Physician )Tj
( )Tj
0 -1.107 Td
[(L)17.4 (ong Island Jewish Medical Center)]TJ
13.107 0 Td
( )Tj
-13.107 -1.107 Td
(NS/LIJ Health Care System)Tj
10.378 0 Td
( )Tj
-10.378 -1.107 Td
[(New Hyde P)54.8 (ark, NY)]TJ
/T1_0 1 Tf
0 -2.214 Td
[(EDITORIAL ADVISOR)92.1 (Y BOARD)]TJ
/TT0 1 Tf
0 -1.107 Td
(James Chan, PharmD, PhD)Tj
/TT1 1 Tf
0 -1.107 Td
[(Associate Clinical P)34.4 (rofessor)]TJ
( )Tj
0 -1.107 Td
(School of Pharmacy)Tj
7.563 0 Td
( )Tj
-7.563 -1.107 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.107 Td
[(San F)54.9 (rancisco)]TJ
/TT0 1 Tf
0 -1.75 Td
[(William T)156.1 (. Elliott, MD, F)36.2 (A)17.5 (CP)]TJ
/TT1 1 Tf
0 -1.107 Td
[(Assistant Clinical P)33.9 (rofessor of Medicine )]TJ
0 -1.107 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.107 Td
[(San F)54.9 (rancisco)]TJ
/TT0 1 Tf
0 -1.75 Td
(David Fiore, MD)Tj
/TT1 1 Tf
0 -1.107 Td
[(P)35.7 (rofessor of F)35.9 (amily Medicine)]TJ
0 -1.107 Td
(University of Nevada)Tj
( )Tj
0 -1.107 Td
[(R)17.5 (eno)]TJ
/TT0 1 Tf
0 -1.75 Td
[(K)17.7 (en Grauer)100.9 (, MD)]TJ
/TT1 1 Tf
0 -1.107 Td
[(P)35.7 (rofessor Emeritus in F)35.1 (amily )]TJ
( )Tj
0 -1.107 Td
(Medicine, College of Medicine,)Tj
0 -1.107 Td
(University of Florida)Tj
0 -1.107 Td
(Gainesville)Tj
/TT0 1 Tf
0 -1.75 Td
(Seema Gupta, MD, MSPH)Tj
/TT1 1 Tf
0 -1.107 Td
[(Clinical Assistant P)33.9 (rofessor)]TJ
0 -1.107 Td
[(Department of F)35.5 (amily )]TJ
( )Tj
0 -1.107 Td
(and Community Health)Tj
( )Tj
0 -1.107 Td
(Joan C. Edwards School of Medicine)Tj
0 -1.107 Td
(Marshall University)Tj
0 -1.107 Td
(Huntington, WV)Tj
/TT0 1 Tf
0 -1.75 Td
[(Martin S. Lipsky)87.5 (, MD)]TJ
/TT1 1 Tf
-0.03 Tc 0.03 Tw 0 -1.107 Td
(Chancellor)Tj
0 Tc 0 Tw 3.889 0 Td
( )Tj
-0.03 Tc -3.889 -1.107 Td
(South Jordan Campus)Tj
0 Tc 7.847 0 Td
( )Tj
-0.03 Tc -7.847 -1.107 Td
[(R)17.5 (oseman University of Health Sciences)]TJ
0 Tc 13.818 0 Td
( )Tj
-0.03 Tc -13.818 -1.107 Td
(South Jordan, UT)Tj
/TT0 1 Tf
0 Tc 0 -1.75 Td
[(Joseph E. Scherger)101.6 (, MD, MPH)]TJ
/TT1 1 Tf
0 -1.107 Td
[(Core F)35.8 (aculty)]TJ
0 -1.107 Td
[(Eisenhower Health F)35.5 (amily Medicine )]TJ
13.922 0 Td
( )Tj
-13.922 -1.107 Td
[(R)17.5 (esidency P)35.5 (rogram)]TJ
0 -1.107 Td
[(Eisenhower Health Center)99.9 (, L)17.5 (a Quinta, )]TJ
0 -1.107 Td
(CA)Tj
0 -1.107 Td
[(Clinical P)34.8 (rofessor)]TJ
0 -1.107 Td
[(K)17.6 (eck School of Medicine)]TJ
0 -1.107 Td
(University of Southern California)Tj
12.409 0 Td
( )Tj
-12.409 -1.107 Td
[(L)17.4 (os Angeles)]TJ
/TT0 1 Tf
0 -1.75 Td
(Allan J. Wilke, MD, MA)Tj
/TT1 1 Tf
0 -1.107 Td
[(P)35.7 (rofessor and Chair)]TJ
7.542 0 Td
( )Tj
-7.542 -1.107 Td
[(Department of F)35.5 (amily Medicine)]TJ
12.045 0 Td
( )Tj
-12.045 -1.107 Td
[(W)54.9 (estern Michigan University)]TJ
10.92 0 Td
( )Tj
-10.92 -1.107 Td
(School of Medicine)Tj
( )Tj
0 -1.107 Td
[(K)17.6 (alamazoo)]TJ
/T1_0 1 Tf
-0.01 Tc 0.01 Tw 0 -2.214 Td
(EDITOR)Tj
/TT0 1 Tf
0 Tw 0 -1.107 Td
(Jonathan Springston)Tj
/T1_0 1 Tf
0.01 Tw 0 -2.214 Td
(EDITOR)Tj
/TT0 1 Tf
0 Tw 0 -1.107 Td
(Jason Schneider)Tj
/T1_0 1 Tf
0 -2.214 Td
(EDITORIAL GROUP MANAGER)Tj
/TT0 1 Tf
0 -1.107 Td
(Leslie Coplin)Tj
/T1_0 1 Tf
0 -2.214 Td
[(ACCREDIT)74 (A)74 (TIONS DIRECTOR)]TJ
/TT0 1 Tf
0 -1.107 Td
(Amy M. Johnson, MSN, RN, CPN)Tj
/CS0 cs 1 scn
/GS0 gs
/TT1 1 Tf
0.01 Tc 9 0 0 9 163.2662 155.4085 Tm
(\225)Tj
/Span<>> BDC
( )Tj
EMC
1.111 0 Td
(describe new findings in the differential diagnosis and treatment of var\
ious diseases;)Tj
-1.111 -1.222 Td
(\225)Tj
/Span<>> BDC
( )Tj
EMC
1.111 0 Td
[(describe the advantages, disadvantages, and controversies surrounding th\
e latest advances in the diagnosis)9.8 ( )]TJ
/Span<>> BDC
-1.111 -1.222 Td
[( )-238 ( )]TJ
EMC
1.111 0 Td
(and treatment of disease;)Tj
-1.111 -1.222 Td
(\225)Tj
/Span<>> BDC
( )Tj
EMC
1.111 0 Td
(identify cost-effective treatment regimens;)Tj
-1.111 -1.222 Td
(\225)Tj
/Span<>> BDC
( )Tj
EMC
1.111 0 Td
(explain the advantages and disadvantages of new disease screening proced\
ures.)Tj
ET
endstream
endobj
70 0 obj
<>
endobj
71 0 obj
<>
endobj
72 0 obj
<>
endobj
73 0 obj
<>
endobj
80 0 obj
<>
endobj
81 0 obj
<>stream
HdNV{q)>J\> i\?m 6eȷ<O/fst]~x{_Nϯ7ww˛oxx2r/?2އp?D??yz{qfzOt:m-_7͆"uDsF'OuOD'&2G'j~"7vG?j$O ?O'I?ɟ'$O ?O'I?ɟ'3,Ɵ?gYyV2ee*)U,S,XXVLbbY2Ų++*V(VTPXXQBbbE
ŊnL_//?R_/WU_W+*_WU_W+*_o7M7&o
o7M7&o
:zX.oز>*+zR9OS Mb
endstream
endobj
82 0 obj
<>stream
HtV TT[GdaeF@"0,b$
.5"d%DQc1VX%T
VFQc]AK{?99; 8ax$>5̰9-=4&ge5
Gg//jҙ"{R7g+I+iMm|R(g)@|r*tl
02BV }O̢ܢ}
eV~f75wb